Changzhou Qianhong Biopharma CO.,LTD

¥6.45As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002550Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (0.10%)
Div yield 2.33%
ROE 7.28%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.09
PE TTM 35.03
TSR TTM (28.95%)
Mkt cap ¥8.061B
ROIC 6.33%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.43
(0.35%)
(69.59%)
Hold 12|2|12|10|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.07
0.08
(6.53%)
(11.37%)
(7.77%)
3.84%
Revenue¥M
560.9
580.3
577.3
572.0
15.66%
14.74%
11.09%
5.50%
Peers (US$1.208B)
Cap (US$)
PE
1.175B
23.26x
Capital
TTM
5Y
10Y
Leveragex
1.397
(0.033)
(0.028)
EBIT/Intx
1.297
0.119
0.107
Own earn%
(3.04)
(375.96)
(311.57)
Sh yield%
27.28
31.31
36.08
Owners
Insiders/Inst%
14.38
84.33
Short interest%
5.85
SBC / revenue%
0.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
4–12
$1 testx
−1.3
Incr. ROIC%
67